Adaptation of the nitrate and Griess reaction methods for the measurement of serum nitrate plus nitrate levels
We would like to comment on the publication of Giovannoni et al,' which deals with the determination of nitrate and nitrate in serum. In their paper the authors state that deproteinization of serum samples using ZnS04 leads to artefacts in the assay for nitrite and is therefore not suitable. Giovannoni et al. discuss our publication on this subject," since our method employs ZnS04 deproteinization. The authors argue that we were unable to observe the artefacts caused by ZnS04 and chloride ions present in serum or PBS (phosphate-buffered saline), since our nitrite standards were diluted in distilled water. We have a different opinion on this statement for the following reasons:
as demonstrated in our previous report," recovery of nitrite standards prepared in plasma or serum and subjected to ZnS04 deproteinization is almost 100% compared to nitrite standards prepared in distilled water 2 in our method plasma and serum samples were diluted four fold in distilled water diluting all ions, including chloride ionp resent in serum or plasma? 3 as shown in Table I , we could not reproduce the findings of Giovannoni et al. Nitrite standards were prepared in PBS; PBS diluted four fold in distilled water; serum diluted four fold in distilled water and serum diluted four fold in PBS. All diluents yielded similar values in the Griess assay as nitrite standards prepared in distilled water over the entire concentration range tested (Table I) .
The reason for this discrepancy may originate from the differences in ZnS04 concentrations used to deproteinize serum samples. As stated in our publication we use a final concentration of 15gil ZnS04e7H20 corresponding to approximately 52 rnmol/L, 2 In contrast, Giovannoni et al. used A second comment concerns the conditions for reduction of nitrate to nitrite. Giovannoni et al. claim that the optimal time to convert nitrite into nitrite is 180 min. In contrast, in our study and many others, 20-30 min reduction at 3TC is usually sufficient to obtain complete reduction. v Again, the reason for this discrepancy remains to be elucidated. Compared to our method, Giovannoni et al. use similar amounts of nitrate reductase, but lower amounts of NADPH (25 JLmol/L versus 50 /Lmol/L) and they omit FAD (flavin adenine dinucleotide), a cofactor for nitrate reductase, which we include at 5/Lmol/L during reduction.? In addition, we perform the reduction at 3TC, whereas Giovannoni et al. reduce their samples at room temperature.
In summary, using the conditions described in our study we have never observed any artefacts caused by the use of ZnS04. In addition, we obtain quantitative reduction of nitrate using nitrate reductase in 20-30 min at 3TC when FAD is included in the reaction mixture. 
Authors' reply
We thank Dr Moshage and Professor Jansen for bringing to our attention the discrepancies in our assays. We developed our assay using the published method of Hevel and Marietta J.2 using nitrate reductase from Aspergillus species (Boehringer Mannheim, catalogue No. 981 249), in which a final concentration of 25 J.lmol/L of NADPH is used. Hevel and Marietta do not use flavin adenine dinucleotide (FAD)Y Using their methods we have a greater than 90% recovery.' However, FAD may be required in the assay as we have had reports of sub-optimal recoveries from investigators using methods with other sources of nitrate reductase. 
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Improving the quality of near-patient blood glucose measurement
A G Rumley! in his paper demonstrated an improvement in reliability in ncar-patient glu-
Letters 155
cose testing (NPGT) as a result of introducing quality control and improved training. Similar findings have been reported by others but all may underestimate initial and continuing unreliability of NPGT. The reliability NPGT is highly operatordependent and wards commonly have 30 or more staff engaged in such testing. Inadequate blood collection and application is a major source of gross errors-. The use of aqueous glucose solutions and the distribution of such samples to wards rather than individuals underestimate unreliability but is a good start.
We described a proficiency score-for assessing the reliability of NPGT by comparison of NPGT results with blood glucose measured by the laboratory on blood spots collected simultaneously to reagent strip measurements. This system was initially established to identify diabetic patients whose self monitoring of blood glucose is insufficiently reliable to be used as a basis for treatment and it assesses the whole procedure: blood collection as well as use of reagent/meters. Low proficiency scores highlight unreliability that might otherwise not be detected. They do not address either deliberate falsification of self monitoring data by patients, as described by Mazze et al.,) or inappropriate use of capillary samples which has been the subject of a Safety Notice" and is of particular concern in acute medicine. A modified scoring system has now been de-veloped which is also used to assess staff training in diabetes and blood glucose measurement; demonstration of acceptable reliability is a pre-requisite for issue of Certificates of Competence. The blood spot method has also been superseded by blood glucose measurements using an APEC glucose analyser and samples collected into EDTA/fluoride micro-tubes: a less labour intensive, more precise and accurate comparison method. The system is also used to evaluate glucose strips and meter systems in actual use rather than the potential performance assessed by a laboratory.
Proficiency scoring is now being introduced for individual ward staff to assess their reliability at NPGT after a I h instruction session, to demonstrate continuing competence annually and to provide data for clinical audit. Each ward has appointed two pathology link nurses, who must hold a Certificate of Competence, to coordinate this and other near-patient testing
